Influence of propafenone on the anticonvulsant activity of various novel antiepileptic drugs in the mouse maximal electroshock model

被引:8
作者
Borowicz-Reutt, Kinga K. [1 ]
Poplawska, Monika [1 ]
Banach, Monika [1 ]
Wroblewska, Dorota [1 ]
机构
[1] Med Univ Lublin, Dept Pathophysiol, Independent Unit Expt Neuropathophysiol, Lublin, Poland
关键词
Propafenone; New antiepileptic drugs; Maximal electroshock seizures; Interactions; CALCIUM-CHANNEL BLOCKERS; SUDDEN UNEXPECTED DEATH; BETA-ADRENOCEPTOR ANTAGONISTS; GATED SODIUM-CHANNELS; ATRIAL-FIBRILLATION; ANTIARRHYTHMIC-DRUGS; INDUCED SEIZURES; THERAPEUTIC TARGETS; HCN CHANNELS; EPILEPSY;
D O I
10.1016/j.pharep.2017.11.014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The main mechanism of action of propafenone (antiarrhythmic drug) involves the inhibition of the fast inward sodium current during phase 0 of the action potential. Sodium channel-blocking activity is also characteristic for some antiepileptic drugs. Therefore, it could be assumed that propafenone may also affect seizures. In the present study, we evaluated the effect of propafenone on the protective effect of oxcarbazepine, lamotrigine, topiramate and pregabalin against the maximal electroshock-induced seizures in mice. Methods: Anticonvulsant activity of propafenone was assessed with the maximal electroshock seizure threshold (MEST) test. Influence of propafenone on the anticonvulsant activity of antiepileptic drugs was estimated in the mouse maximal electroshock model (MES). Drug-related adverse effects were determined in the chimney test (motor coordination) and passive-avoidance task (long-term memory). Brain concentrations of antiepileptics were assessed by fluorescence polarization immunoassay. Results: Propafenone at doses 60-90 mg/kg significantly increased the threshold of seizures, in turn at doses 5-50 mg/kg did not affect this parameter. Administration of propafenone at the subthreshold dose of 50 mg/kg increased antielectroshock activity of oxcarbazepine, topiramate and pregabalin, but not that of lamotrigine. As regards adverse effects, propafenone alone and in combination with antiepileptic drugs did not significantly impair motor coordination or long-term memory in mice. Propafenone (50 mg/kg) significantly increased the brain level of pregabalin. Brain concentrations of topiramate and oxcarbazepine were not affected. Conclusion: Our findings show that propafenone has own anticonvulsant action and enhances efficacy of oxcarbazepine, topiramate and pregabalin, but not that of lamotrigine, at least in experimental condition. (c) 2017 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.
引用
收藏
页码:481 / 487
页数:7
相关论文
共 61 条
[1]  
AKKAN AG, 1989, INT J CLIN PHARM TH, V27, P255
[2]  
ALEXANDER GJ, 1986, NEUROBEH TOXICOL TER, V8, P231
[3]   Propafenone enhances the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock model [J].
Banach, Monika ;
Piskorska, Barbara ;
Borowicz-Reutt, Kinga K. .
PHARMACOLOGICAL REPORTS, 2016, 68 (03) :555-560
[4]   HCN channels Function and clinical implications [J].
Benarroch, Eduardo E. .
NEUROLOGY, 2013, 80 (03) :304-310
[5]  
BOISSIER J.-R, 1960, MED EXPTL, V3, P81
[6]   Mexiletine and its Interactions with Classical Antiepileptic Drugs: An Isobolographic Analysis [J].
Borowicz-Reutt, Kinga K. ;
Banach, Monika ;
Piskorska, Barbara .
NEUROCHEMICAL RESEARCH, 2016, 41 (05) :1185-1191
[7]   Therapeutic drug monitoring: antiarrhythmic drugs [J].
Campbell, TJ ;
Williams, KM .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (04) :307-319
[8]   THE MAXIMAL ELECTROSHOCK SEIZURE (MES) MODEL IN THE PRECLINICAL ASSESSMENT OF POTENTIAL NEW ANTIEPILEPTIC DRUGS [J].
Castel-Branco, M. M. ;
Alves, G. L. ;
Figueiredo, I. V. ;
Falcao, A. C. ;
Caramona, M. M. .
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2009, 31 (02) :101-106
[9]   NaV1.1 channels and epilepsy [J].
Catterall, William A. ;
Kalume, Franck ;
Oakley, John C. .
JOURNAL OF PHYSIOLOGY-LONDON, 2010, 588 (11) :1849-1859
[10]   Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias - Report from the flecainide and propafenone Italian study (FAPIS) group [J].
Chimienti, M ;
Cullen, MT ;
Casadei, G .
EUROPEAN HEART JOURNAL, 1995, 16 (12) :1943-1951